Androgen replacement via testosterone stimulation of castrated mice secondary to prostate cancer xenografts caused an increase in IGFBP5, indicating IGFBP5 may be regulated by the androgen receptor (AR) in some cases (106). Here, IGFBP5 is linked to prostate carcinoma.